Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite
A Single Arm, Single-Center, Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite
Status: Archived
mi
from
Centerville, OH
A Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite
A Single Arm, Single-Center, Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite
Status: Archived
Updated: 1/1/1970
Cornerstone Medical Center
mi
from
Centerville, OH
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics of the Vastus Lateralis After Sub-maximal Exercise in Patients With Mitochondrial Myopathy
Status: Archived
mi
from
Boston, MA
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics of the Vastus Lateralis After Sub-maximal Exercise in Patients With Mitochondrial Myopathy
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Athens, AL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
North Alabama Research Center
mi
from
Athens, AL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
North Miami Beach, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Innovative Medical Research of South Florida, Inc
mi
from
North Miami Beach, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Birmingham, AL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Achieve Clinical Research
mi
from
Birmingham, AL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Birmingham, AL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Alabama Clinical Therapeutic, LLC
mi
from
Birmingham, AL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Jackson, MS
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
G.V. (Sonny) Montgomery VAMC
mi
from
Jackson, MS
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Montgomery, AL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Healthscan Research
mi
from
Montgomery, AL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Phoenix, AZ
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Anasazi Internal Medicine PC
mi
from
Phoenix, AZ
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Little Rock, AR
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Aureas Research, Inc
mi
from
Little Rock, AR
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Davis, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
California Clinical Research, Inc.
mi
from
Davis, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Foothill Ranch, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Family Medical Center
mi
from
Foothill Ranch, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Laguna Hills, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
South Orange County Surgical Medical Group
mi
from
Laguna Hills, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Buena Park, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Clear Vision Research
mi
from
Buena Park, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Orange, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
SDS Clinical Trials
mi
from
Orange, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Riverside, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Probe Clinical Research Corporation
mi
from
Riverside, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Lincoln, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Clinical Trials Research
mi
from
Lincoln, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Westlake Village, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Westlake Medical Research
mi
from
Westlake Village, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Denver, CO
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Mountain View Clinical Research
mi
from
Denver, CO
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
St Petersburg, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Meridien Research
mi
from
St Petersburg, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Bradenton, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Coastal Orthopedics & Pain Management
mi
from
Bradenton, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Clearwater, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Florida Research & Testing, LLC
mi
from
Clearwater, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
DeLand, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Avail Clinical Research
mi
from
DeLand, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
La Quinta, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
S.T.A.R. Orthopaedics, Inc.
mi
from
La Quinta, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Hialeah, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Palm Springs Research Institute
mi
from
Hialeah, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Miami, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Kendall South Medical Center, Inc.
mi
from
Miami, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Naples, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Gastroenterology Group of Naples
mi
from
Naples, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Naples, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Physicians Regional Medical Group
mi
from
Naples, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Boston, MA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Ocala, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Paddock Park Clinical Research
mi
from
Ocala, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Oldsmar, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Journey Research, Inc.
mi
from
Oldsmar, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Pembroke Pines, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Andres Patron, DO, PA
mi
from
Pembroke Pines, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Pinellas Park, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Advent Clinical Research Centers
mi
from
Pinellas Park, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Royal Palm Beach, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Orthopedic Research Institite
mi
from
Royal Palm Beach, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Sanford, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
International Clinical Research
mi
from
Sanford, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Sarasota, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Sarasota Pain Medicine Research
mi
from
Sarasota, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Citrus Park-Fern Lake, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Tampa Clinical Research
mi
from
Citrus Park-Fern Lake, FL
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Columbus, GA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Southeastern Regional Research Group
mi
from
Columbus, GA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Newnan, GA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Better Health Clinical Research
mi
from
Newnan, GA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Atlanta, GA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Clinical Research Atlanta
mi
from
Atlanta, GA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Boise City, ID
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Advanced Clinical Research
mi
from
Boise City, ID
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Boise, ID
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Sonora Clinical Research
mi
from
Boise, ID
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Meridian, ID
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Nautical Clinical Research
mi
from
Meridian, ID
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Indianapolis, IN
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Anesthesia/Pain Control Indiana University School of Medicine
mi
from
Indianapolis, IN
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Council Bluffs, IA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Ridge Family Practice
mi
from
Council Bluffs, IA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Fayette, KY
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Kentucky Medical Research Center
mi
from
Fayette, KY
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Baton Rouge, LA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Horizon Research Group
mi
from
Baton Rouge, LA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Brockton, MA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Miray Medical Center
mi
from
Brockton, MA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Springfield, MA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
The Research Institute
mi
from
Springfield, MA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
mi
from
Weymouth, MA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Coastal Research Associates
mi
from
Weymouth, MA